Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To estimate the risk of cholesteatoma in patients with alpha-1 antitrypsin deficiency (AATD) compared to the general population using time-to-event analysis.

Methods: We conducted a nationwide nested cohort study identifying all patients with AATD in Denmark and subsequently matching each case with up to 10 controls based on age, sex, and municipality. Hazard ratios (HR) of cholesteatoma by AATD were calculated using Cox regression analysis adjusted for age and sex.

Results: The study identified 2702 individuals with AATD and 26,750 control subjects. Individuals with AATD versus controls had a HR for cholesteatoma surgery of 3.62 (95% CI: 1.93-6.80) and a HR for non-cholesteatoma surgery of 1.40 (1.04-1.89).

Conclusion: Individuals with AATD had a 3.6-fold increased risk of cholesteatoma surgery compared with matched controls without AATD. The data support that AATD contributes to pathophysiological processes underlying the development of cholesteatoma.

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.70091DOI Listing

Publication Analysis

Top Keywords

risk cholesteatoma
12
individuals aatd
12
increased risk
8
alpha-1 antitrypsin
8
antitrypsin deficiency
8
cohort study
8
aatd
8
cholesteatoma surgery
8
cholesteatoma
6
individuals
4

Similar Publications

Objective: To estimate the risk of cholesteatoma in patients with alpha-1 antitrypsin deficiency (AATD) compared to the general population using time-to-event analysis.

Methods: We conducted a nationwide nested cohort study identifying all patients with AATD in Denmark and subsequently matching each case with up to 10 controls based on age, sex, and municipality. Hazard ratios (HR) of cholesteatoma by AATD were calculated using Cox regression analysis adjusted for age and sex.

View Article and Find Full Text PDF

External ear canal (EEC) stenosis, often associated with cholesteatoma, carries a high risk of postoperative restenosis despite surgical intervention. While individualized implants offer promise in preventing restenosis, the high morphological variability of EECs and the lack of standardized definitions hinder systematic implant design. This study aimed to characterize individual EEC morphology and to develop a validated automated segmentation system for efficient implant preparation.

View Article and Find Full Text PDF

: Obstructive Eustachian tube dysfunction (OETD) is common in adults and may lead to middle-ear conditions such as atelectasis and cholesteatoma. The ETDQ-7 questionnaire is used to assess symptom severity. Balloon dilation of the Eustachian tube (BDET) is a minimally invasive treatment with variable outcomes.

View Article and Find Full Text PDF

[The microbiome from ear to nasopharynx].

HNO

September 2025

HNO-Uniklinik Münster, Klinik und Poliklinik für Hals-Nasen-Ohrenkrankheiten, Universitätsmedizin Münster, Kardinal-von-Galen-Ring 10, 48149, Münster, Deutschland.

The results of a scoping review on the current state of scientific knowledge in relation to the various anatomical areas from the nasopharynx to the ear are presented. In brief, foreign bodies in the area of the outer ear (hearing aids, piercings) change the microbiome and favor a moist environment. Middle ear infections also lead to changes in the fecal microbiome.

View Article and Find Full Text PDF

Genome- and Exome-Wide Identification of Common-to-Rare Variants Associated with Middle Ear Cholesteatoma.

Otol Neurotol

July 2025

Department of Otolaryngology-Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, China.

Hypothesis: To investigate the genetic susceptibility of middle ear cholesteatoma (MEC) and construct an MEC risk prediction model by integrating genetic risk with clinical factors.

Background: MEC represents a relatively rare disorder that is associated with high morbidity, whereas its genetic etiology remains poorly understood.

Methods: Using genetic data from the UK Biobank (UKB), we performed both genome-wide association study (GWAS) and exome-wide association study (ExWAS) involving 702 MEC patients and 491,503 controls.

View Article and Find Full Text PDF